Alexander Maxwell
Value, growth, long-term horizon, biotech

LPath Inc. A Small Biotechnology Company With Big Potential

One of the hardest goals to accomplish within the biotechnology sector is to find a stock that has the potential to be huge within a few years. I believe that LPath (LPTN) represents a significant opportunity for investors, and thus represents a compelling chance at significant upside for investors who are focused upon the long term. Currently, LPath has a promising pipeline that is progressing through the stages of clinical development, and this pipeline represents a compelling opportunity for investors. Add in the fact that LPath has a partnership with one of the largest pharmaceutical companies in the world for a rather important product, and the potential for this small cap stock does seem to be very large. LPath appears...

Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
IDEA GENERATORXExclusive access to 10 PRO ideas every day
INVESTING IDEAS LIBRARYXExclusive access to PRO library of more than 15,000 ideas
SECTOR EXPERT NETWORKXExclusive access to all sector experts for direct consultation
PERFORMANCE TRACKINGXTrack performance of all PRO stock ideas
PROFESSIONAL TOOLSXProfessional Idea Filters to zero-in based on industry, market cap and more
"In just the first month of using PRO, I used it to generate two ideas which were actionable for me. As a result of these two positions, I have earned more than 20 times the annual subscription costs for PRO."Michael Yagemann, Greenbridge Capital
"I am pleasantly surprised with the scope of small and mid-cap coverage PRO offers. You can't find that any where else."Patrick Rice, Mainstay Capital Management
You may cancel at any time for any reason, and receive a prompt refund for membership on months paid and not used (max. 6 months). Details